CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis.
Shen W, Zhang X, Tang J, Zhang Z, Du R, Luo D, Liu X, Xia Y, Li Y, Wang S, Yan S, Yang W, Xiang R, Luo N, Luo Y, Li J.
Shen W, et al.
Theranostics. 2021 Jan 1;11(5):2297-2317. doi: 10.7150/thno.51000. eCollection 2021.
Theranostics. 2021.
PMID: 33500726
Free PMC article.